Tnf Pharmaceuticals, Stock Price History
| TNFA Stock | 1.29 0.07 5.15% |
Below is the normalized historical share price chart for TNF Pharmaceuticals, extending back to July 24, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of TNF Pharmaceuticals, stands at 1.29, as last reported on the 23rd of December, with the highest price reaching 1.49 and the lowest price hitting 1.29 during the day.
If you're considering investing in TNF Stock, it is important to understand the factors that can impact its price. TNF Pharmaceuticals, appears to be abnormally volatile, given 3 months investment horizon. TNF Pharmaceuticals, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0423, which indicates the firm had a 0.0423% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for TNF Pharmaceuticals,, which you can use to evaluate the volatility of the company. Please review TNF Pharmaceuticals,'s risk adjusted performance of 0.0505, and Coefficient Of Variation of 1910.81 to confirm if our risk estimates are consistent with your expectations.
At present, TNF Pharmaceuticals,'s Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 19.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 1.1 M. . At present, TNF Pharmaceuticals,'s Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 0.24, whereas Price Earnings Ratio is projected to grow to (0.70). TNF Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of January 2014 | 200 Day MA 3.3706 | 50 Day MA 1.8005 | Beta 2.673 |
TNF |
Sharpe Ratio = 0.0423
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TNFA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.97 actual daily | 70 70% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average TNF Pharmaceuticals, is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TNF Pharmaceuticals, by adding it to a well-diversified portfolio.
Price Book 0.4357 | Book Value (0.02) | Enterprise Value -9.5 M | Shares Float 2.2 M | Shares Outstanding 2.4 M |
TNF Pharmaceuticals, Stock Price History Chart
There are several ways to analyze TNF Stock price data. The simplest method is using a basic TNF candlestick price chart, which shows TNF Pharmaceuticals, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 15, 2024 | 1.8 |
| Lowest Price | December 16, 2024 | 1.09 |
TNF Pharmaceuticals, December 23, 2024 Stock Price Synopsis
Various analyses of TNF Pharmaceuticals,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell TNF Stock. It can be used to describe the percentage change in the price of TNF Pharmaceuticals, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of TNF Stock.| TNF Pharmaceuticals, Price Action Indicator | (0.13) | |
| TNF Pharmaceuticals, Price Daily Balance Of Power | (0.35) | |
| TNF Pharmaceuticals, Price Rate Of Daily Change | 0.95 |
TNF Pharmaceuticals, December 23, 2024 Stock Price Analysis
TNF Stock Price History Data
The price series of TNF Pharmaceuticals, for the period between Tue, Sep 24, 2024 and Mon, Dec 23, 2024 has a statistical range of 0.71 with a coefficient of variation of 13.97. The price distribution for the period has arithmetic mean of 1.42. The median price for the last 90 days is 1.4. The company completed stock split (1:30) on 15th of February 2024. TNF Pharmaceuticals, had dividends distributed to its stock-holders on 2019-11-25.| Open | High | Low | Close | Volume | ||
12/23/2024 | 1.36 | 1.49 | 1.29 | 1.29 | ||
12/23/2024 | 1.36 | 1.49 | 1.29 | 1.29 | ||
| 12/20/2024 | 1.39 | 1.49 | 1.35 | 1.36 | 126,306 | |
| 12/19/2024 | 1.57 | 1.58 | 1.34 | 1.47 | 408,777 | |
| 12/18/2024 | 1.43 | 1.53 | 1.33 | 1.45 | 596,369 | |
| 12/17/2024 | 1.12 | 1.26 | 1.09 | 1.23 | 83,868 | |
| 12/16/2024 | 1.15 | 1.20 | 1.07 | 1.09 | 153,900 | |
| 12/13/2024 | 1.20 | 1.22 | 1.05 | 1.15 | 149,925 | |
| 12/12/2024 | 1.20 | 1.29 | 1.17 | 1.19 | 108,700 | |
| 12/11/2024 | 1.48 | 1.50 | 1.12 | 1.22 | 437,646 | |
| 12/10/2024 | 1.55 | 1.64 | 1.41 | 1.57 | 1,353,359 | |
| 12/09/2024 | 1.33 | 1.64 | 1.33 | 1.41 | 980,946 | |
| 12/06/2024 | 1.24 | 1.25 | 1.21 | 1.24 | 37,761 | |
| 12/05/2024 | 1.20 | 1.27 | 1.16 | 1.22 | 41,822 | |
| 12/04/2024 | 1.10 | 1.22 | 1.10 | 1.21 | 64,619 | |
| 12/03/2024 | 1.11 | 1.15 | 1.07 | 1.13 | 37,300 | |
| 12/02/2024 | 1.12 | 1.15 | 1.10 | 1.10 | 33,540 | |
| 11/29/2024 | 1.14 | 1.15 | 1.10 | 1.13 | 23,977 | |
| 11/27/2024 | 1.32 | 1.36 | 1.14 | 1.16 | 109,064 | |
| 11/26/2024 | 1.41 | 1.42 | 1.33 | 1.35 | 16,628 | |
| 11/25/2024 | 1.39 | 1.50 | 1.36 | 1.40 | 55,386 | |
| 11/22/2024 | 1.39 | 1.39 | 1.21 | 1.34 | 14,104 | |
| 11/21/2024 | 1.22 | 1.40 | 1.19 | 1.36 | 24,600 | |
| 11/20/2024 | 1.16 | 1.26 | 1.14 | 1.23 | 64,379 | |
| 11/19/2024 | 1.20 | 1.22 | 1.12 | 1.15 | 28,300 | |
| 11/18/2024 | 1.20 | 1.27 | 1.19 | 1.22 | 15,900 | |
| 11/15/2024 | 1.16 | 1.27 | 1.15 | 1.20 | 44,600 | |
| 11/14/2024 | 1.26 | 1.33 | 1.15 | 1.23 | 36,200 | |
| 11/13/2024 | 1.39 | 1.39 | 1.25 | 1.25 | 15,671 | |
| 11/12/2024 | 1.39 | 1.42 | 1.25 | 1.30 | 92,800 | |
| 11/11/2024 | 1.38 | 1.44 | 1.37 | 1.42 | 56,885 | |
| 11/08/2024 | 1.37 | 1.40 | 1.26 | 1.34 | 8,030 | |
| 11/07/2024 | 1.30 | 1.37 | 1.27 | 1.35 | 19,200 | |
| 11/06/2024 | 1.30 | 1.37 | 1.27 | 1.32 | 11,460 | |
| 11/05/2024 | 1.32 | 1.39 | 1.32 | 1.34 | 12,800 | |
| 11/04/2024 | 1.36 | 1.40 | 1.30 | 1.31 | 10,822 | |
| 11/01/2024 | 1.43 | 1.43 | 1.32 | 1.33 | 31,724 | |
| 10/31/2024 | 1.43 | 1.44 | 1.36 | 1.42 | 28,898 | |
| 10/30/2024 | 1.56 | 1.56 | 1.42 | 1.46 | 23,100 | |
| 10/29/2024 | 1.70 | 1.74 | 1.46 | 1.53 | 42,100 | |
| 10/28/2024 | 1.67 | 1.80 | 1.67 | 1.76 | 19,507 | |
| 10/25/2024 | 1.74 | 1.78 | 1.67 | 1.68 | 8,900 | |
| 10/24/2024 | 1.76 | 1.79 | 1.67 | 1.78 | 30,020 | |
| 10/23/2024 | 1.68 | 1.72 | 1.65 | 1.67 | 10,004 | |
| 10/22/2024 | 1.66 | 1.75 | 1.61 | 1.68 | 21,000 | |
| 10/21/2024 | 1.72 | 1.80 | 1.60 | 1.64 | 30,261 | |
| 10/18/2024 | 1.75 | 1.89 | 1.65 | 1.76 | 39,629 | |
| 10/17/2024 | 1.56 | 1.88 | 1.54 | 1.77 | 26,307 | |
| 10/16/2024 | 1.80 | 1.82 | 1.67 | 1.69 | 48,900 | |
| 10/15/2024 | 1.64 | 1.95 | 1.62 | 1.80 | 132,626 | |
| 10/14/2024 | 1.61 | 1.64 | 1.52 | 1.61 | 9,108 | |
| 10/11/2024 | 1.47 | 1.72 | 1.47 | 1.65 | 12,357 | |
| 10/10/2024 | 1.52 | 1.52 | 1.43 | 1.52 | 9,193 | |
| 10/09/2024 | 1.45 | 1.54 | 1.44 | 1.52 | 19,000 | |
| 10/08/2024 | 1.49 | 1.51 | 1.41 | 1.50 | 33,407 | |
| 10/07/2024 | 1.56 | 1.57 | 1.41 | 1.51 | 18,218 | |
| 10/04/2024 | 1.44 | 1.55 | 1.44 | 1.55 | 11,735 | |
| 10/03/2024 | 1.65 | 1.70 | 1.41 | 1.42 | 62,899 | |
| 10/02/2024 | 1.49 | 1.89 | 1.48 | 1.72 | 331,515 | |
| 10/01/2024 | 1.64 | 1.65 | 1.43 | 1.45 | 13,071 | |
| 09/30/2024 | 1.51 | 1.63 | 1.51 | 1.62 | 8,941 |
About TNF Pharmaceuticals, Stock history
TNF Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TNF is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TNF Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TNF Pharmaceuticals, stock prices may prove useful in developing a viable investing in TNF Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.5 M | 1.1 M |
TNF Pharmaceuticals, Stock Technical Analysis
TNF Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
TNF Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TNF Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of TNF Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TNF to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0505 | |||
| Jensen Alpha | 0.4105 | |||
| Total Risk Alpha | 0.1831 | |||
| Sortino Ratio | 0.0517 | |||
| Treynor Ratio | (1.71) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |